Miracell Expands Export Markets with Stem Cell System “Smart Mcell 2”
Miracell Expands Export Markets with Stem Cell System “Smart Mcell 2”Stem cell isolation within 17 minutes, with cell viability rates of up to 98% 【Health Digest | Reporter Choi Min-young】 Stem cell specialist Miracell (CEO Shin Hyun-soon) participated in the International Society of Aesthetic Plastic Surgery (ISAPS) World Congress, held in Istanbul, Turkey from September 20th to 24th, to showcase its stem cell extraction system, the “Smart Mcell 2.” According to the company, the “Smart Mcell 2” stem cell extraction system can be applied to a wide range of regenerative medicine procedures across the body. By incorporating stem cells into existing surgeries or performing them directly, the system enhances the regenerative capacity of cells, maximizing therapeutic effects. Stem cell treatments are also actively being used in the field of dermatological plastic surgery. Over 400 faculty members from over 70 countries participated in the 26th International Society of Aesthetic Plastic Surgery. CEO Shin Hyun-soon stated, “With growing interest in anti-aging, demand for stem cell systems has recently surged in the cosmetic surgery field.‘Smart Mcell 2’ boasts stem cell isolation within 17 minutes and a cell viability rate of up to 98%.” “We will work diligently to promote domestic stem cell technology, which plays a key role in increasing patient satisfaction in regenerative medicine, to the global biotechnology market.” Meanwhile, Miracell plans to attend the IMCAS International Congress of Aesthetic Plastic Surgery, to be held in Bangkok, Thailand, starting September 29th.